Follow
David Janzén
David Janzén
Unknown affiliation
Verified email at warwick.ac.uk
Title
Cited by
Cited by
Year
Targeted delivery of antisense oligonucleotides to pancreatic β-cells
C Ämmälä, WJ Drury III, L Knerr, I Ahlstedt, P Stillemark-Billton, ...
Science advances 4 (10), eaat3386, 2018
1692018
Nonlinear mixed-effects modelling for single cell estimation: when, why, and how to use it
M Karlsson, DLI Janzén, L Durrieu, A Colman-Lerner, MC Kjellsson, ...
BMC systems biology 9, 1-15, 2015
572015
Parameter identifiability of fundamental pharmacodynamic models
DLI Janzén, L Bergenholm, M Jirstrand, J Parkinson, J Yates, ND Evans, ...
Frontiers in Physiology 7, 590, 2016
562016
Glucagon like peptide 1 receptor agonists for targeted delivery of antisense oligonucleotides to pancreatic beta cell
L Knerr, TP Prakash, R Lee, WJ Drury III, M Nikan, W Fu, E Pirie, LD Maria, ...
Journal of the American Chemical Society 143 (9), 3416-3429, 2021
542021
Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators
R Hendrickx, E Lamm Bergström, DLI Janzén, M Fridén, U Eriksson, ...
CPT: pharmacometrics & systems pharmacology 7 (3), 147-157, 2018
392018
Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates
L Weidolf, A Björkbom, A Dahlén, M Elebring, P Gennemark, M Hölttä, ...
Drug discovery today 26 (10), 2244-2258, 2021
282021
In vitro and in vivo evaluation of 3D printed capsules with pressure triggered release mechanism for oral peptide delivery
S Berg, J Krause, A Björkbom, K Walter, S Harun, A Granfeldt, D Janzén, ...
Journal of Pharmaceutical Sciences 110 (1), 228-238, 2021
282021
Physiologically based pharmacokinetic model of itraconazole and two of its metabolites to improve the predictions and the mechanistic understanding of CYP3A4 drug-drug interactions
LP Garcia, D Janzén, KP Kanebratt, H Ericsson, H Lennernäs, A Lundahl
Drug Metabolism and Disposition 46 (10), 1420-1433, 2018
282018
Three novel approaches to structural identifiability analysis in mixed-effects models
DLI Janzén, M Jirstrand, MJ Chappell, ND Evans
Computer Methods and Programs in Biomedicine 171, 141-152, 2019
262019
Model‐based assessment of variability in isoniazid pharmacokinetics and metabolism in patients co‐infected with tuberculosis and HIV: implications for a novel dosing strategy
J Sundell, E Bienvenu, D Janzén, S Birgersson, A Äbelö, M Ashton
Clinical Pharmacology & Therapeutics 108 (1), 73-80, 2020
212020
Antisense therapy attenuates phospholamban p.(Arg14del) cardiomyopathy in mice and reverses protein aggregation
TR Eijgenraam, NM Stege, V Oliveira Nunes Teixeira, R de Brouwer, ...
International Journal of Molecular Sciences 23 (5), 2427, 2022
152022
Extending existing structural identifiability analysis methods to mixed-effects models
DLI Janzén, M Jirstrand, MJ Chappell, ND Evans
Mathematical Biosciences 295, 1-10, 2018
92018
Evaluation in pig of an intestinal administration device for oral peptide delivery
S Berg, T Uggla, M Antonsson, SF Nunes, M Englund, L Rosengren, ...
Journal of Controlled Release 353, 792-801, 2023
82023
Characterization of cell-to-cell variation in nuclear transport rates and identification of its sources
L Durrieu, A Bush, A Grande, R Johansson, D Janzén, A Katz, ...
Iscience 26 (1), 2023
72023
Diffusive molecular communication with a spheroidal receiver for organ-on-chip systems
H Arjmandi, M Zoofaghari, M Rezaei, K Kanebratt, L Vilen, D Janzen, ...
ICC 2023-IEEE International Conference on Communications, 4464-4469, 2023
62023
Structural Identifiability in Mixed-Effects Models: Two different approaches
D Janzén
9th IFAC Symposium on Biological and Medical Systems, 2015
42015
Standard two-stage and Nonlinear mixed effect modelling for determination of cell-to-cell variation of transport parameters in Saccharomyces cerevisiae
D Janzén
42012
Spheroidal Molecular Communication via Diffusion: Signaling Between Homogeneous Cell Aggregates
M Rezaei, H Arjmandi, M Zoofaghari, K Kanebratt, L Vilén, D Janzén, ...
IEEE Transactions on Molecular, Biological and Multi-Scale Communications 10 …, 2024
32024
Input estimation for extended-release formulations exemplified with exenatide
M Trägĺrdh, MJ Chappell, JE Palm, ND Evans, DLI Janzén, P Gennemark
Frontiers in Bioengineering and Biotechnology 5, 24, 2017
32017
Structural identifiability and indistinguishability in mixed-effects models
D Janzén
University of Warwick, 2016
22016
The system can't perform the operation now. Try again later.
Articles 1–20